Alzamend Neuro (ALZN) Income from Continuing Operations (2020 - 2026)
Alzamend Neuro (ALZN) recorded Income from Continuing Operations of -$3.03 million in fiscal Q1 2027 (quarter ended Jul 31, 2026), compared with -$2.7 million a year earlier.
Powered by 
Analysis
Alzamend Neuro (ALZN) Income from Continuing Operations (2020 - 2026) Analysis & Trends
On a TTM basis, Alzamend Neuro's Income from Continuing Operations came in at -$9.1 million as of Jul 31, 2026; for FY2026 (ended Apr 30, 2026), it was -$8.77 million.
- Across earlier fiscal years, Income from Continuing Operations came in at -$4.51 million in FY2025, -$9.95 million in FY2024, -$14.88 million in FY2023 and -$12.37 million in FY2022.
- The fiscal Q1 2027 figure is the lowest quarterly Income from Continuing Operations since fiscal Q1 2024.
- Per Business Quant, the preceding three fiscal quarters came in at -$2.87 million (Q4 2026), -$2.2 million (Q3 2026) and -$1 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Alzamend Neuro | 8.35 Mn | 8.35 Mn | - | -3.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -3.03 Mn |
| Apr 30, 2026 | -2.87 Mn |
| Jan 31, 2026 | -2.20 Mn |
| Oct 31, 2025 | -1.00 Mn |
| Jul 31, 2025 | -2.70 Mn |
| Apr 30, 2025 | -1.14 Mn |
| Jan 31, 2025 | -1.04 Mn |
| Oct 31, 2024 | -1.36 Mn |
| Jul 31, 2024 | -974,411.00 |
| Apr 30, 2024 | -851,529.00 |
| Jan 31, 2024 | -2.66 Mn |
| Oct 31, 2023 | -2.91 Mn |
| Jul 31, 2023 | -3.53 Mn |
| Apr 30, 2023 | -3.31 Mn |
| Jan 31, 2023 | -5.43 Mn |
| Oct 31, 2022 | -3.11 Mn |
| Jul 31, 2022 | -3.04 Mn |
| Apr 30, 2022 | -3.87 Mn |
| Jan 31, 2022 | -2.57 Mn |
| Oct 31, 2021 | -3.60 Mn |
API Access
Alzamend Neuro Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();